JP2015528504A5 - - Google Patents

Download PDF

Info

Publication number
JP2015528504A5
JP2015528504A5 JP2015532043A JP2015532043A JP2015528504A5 JP 2015528504 A5 JP2015528504 A5 JP 2015528504A5 JP 2015532043 A JP2015532043 A JP 2015532043A JP 2015532043 A JP2015532043 A JP 2015532043A JP 2015528504 A5 JP2015528504 A5 JP 2015528504A5
Authority
JP
Japan
Prior art keywords
delivery system
drug delivery
level
active ingredient
pharmaceutically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015532043A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015528504A (ja
Filing date
Publication date
Priority claimed from US13/843,718 external-priority patent/US20140073678A1/en
Application filed filed Critical
Publication of JP2015528504A publication Critical patent/JP2015528504A/ja
Publication of JP2015528504A5 publication Critical patent/JP2015528504A5/ja
Pending legal-status Critical Current

Links

JP2015532043A 2012-09-12 2013-09-12 抗疼痛及び抗嘔気及び／又は抗嘔吐組み合わせ組成物 Pending JP2015528504A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261700146P 2012-09-12 2012-09-12
US61/700,146 2012-09-12
US13/843,718 2013-03-15
US13/843,718 US20140073678A1 (en) 2012-09-12 2013-03-15 Anti-pain and anti-nausea and/or vomiting combinatorial compositions
PCT/US2013/059460 WO2014043346A2 (en) 2012-09-12 2013-09-12 Anti-pain and anti-nausea and/or vomiting combinatorial compositions

Publications (2)

Publication Number Publication Date
JP2015528504A JP2015528504A (ja) 2015-09-28
JP2015528504A5 true JP2015528504A5 (enExample) 2016-08-18

Family

ID=50233885

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015532043A Pending JP2015528504A (ja) 2012-09-12 2013-09-12 抗疼痛及び抗嘔気及び／又は抗嘔吐組み合わせ組成物

Country Status (6)

Country Link
US (1) US20140073678A1 (enExample)
EP (1) EP2895145A2 (enExample)
JP (1) JP2015528504A (enExample)
AU (1) AU2013315484A1 (enExample)
CA (1) CA2884757A1 (enExample)
WO (1) WO2014043346A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010522135A (ja) 2006-10-09 2010-07-01 チャールストン ラボラトリーズ，インコーポレイテッド 医薬組成物
JP5714910B2 (ja) 2008-01-09 2015-05-07 チャールストン ラボラトリーズ，インコーポレイテッド 薬学的組成物
EP3311667A1 (en) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
US20140275194A1 (en) * 2013-03-15 2014-09-18 Monosol Rx, Llc Films and drug delivery systems for rizatriptan
WO2015200233A1 (en) 2014-06-24 2015-12-30 Catherine Lee Fast acting orally disintegrating film
JP2017527581A (ja) * 2014-09-09 2017-09-21 チャールストン ラボラトリーズ，インコーポレイテッド 医薬組成物
JP2019507181A (ja) 2016-03-04 2019-03-14 チャールストン ラボラトリーズ，インコーポレイテッド 医薬組成物
WO2018213589A1 (en) 2017-05-17 2018-11-22 Confluence Pharmaceuticals, Llc Formulations of homotaurines and salts thereof
WO2019069123A1 (en) * 2017-10-07 2019-04-11 Zim Laboratories Ltd. METHOD FOR PREPARING A BI OR MULTILAYER FILM, MULTILAYER FILM PRODUCED THEREFROM, AND APPARATUS FOR PRODUCING SUCH MULTILAYER FILMS
DE102017127452A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag Wasserlösliche Polymerklebschichten
WO2022104234A1 (en) * 2020-11-15 2022-05-19 Castor Trevor P Methods for assaying and measuring the efficacy of anti-nausea compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001039836A1 (en) * 1999-12-01 2001-06-07 Natco Pharma Limited A rapid acting freeze dired oral pharmaceutical composition for treating migraine
JP2008534562A (ja) * 2005-03-28 2008-08-28 オレクソ・アクチエボラゲット 偏頭痛の治療に有用な新しい製薬組成物
GB0613925D0 (en) * 2006-07-13 2006-08-23 Unilever Plc Improvements relating to nanodispersions
AU2007304425B2 (en) * 2006-10-02 2013-12-05 Spepharma Ag Non-mucoadhesive film dosage forms
WO2009134336A1 (en) * 2008-04-28 2009-11-05 Zogenix, Inc. Novel formulations for treatment of migraine
US8715715B2 (en) * 2008-11-03 2014-05-06 Nal Pharmaceuticals Ltd. Dosage form for insertion into the mouth
US20100297232A1 (en) * 2009-05-19 2010-11-25 Monosol Rx, Llc Ondansetron film compositions
PT2952191T (pt) * 2009-06-12 2018-11-30 Sunovion Pharmaceuticals Inc Apomorfina sublingual
EP3311667A1 (en) * 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
CN102028672B (zh) * 2010-09-29 2012-08-29 上海现代药物制剂工程研究中心有限公司 微孔海绵状药膜制剂及其制备方法

Similar Documents

Publication Publication Date Title
JP2009536147A5 (enExample)
Mercadante Pharmacotherapy for breakthrough cancer pain
JP2009539761A5 (enExample)
JP2019156859A5 (enExample)
JP2012513955A5 (enExample)
ES2214649T3 (es) Preparado farmaceutico plano para la administracion o liberacion, en la cavidad bucal, de buprenorfina o una sustancia comparable farmacologicamente, y metodo para la produccion del mismo.
JP2022180461A5 (enExample)
JP2009544619A5 (enExample)
CN103096881B (zh) 含有具有不愉快味道的药物的膜制剂
US20130153459A1 (en) Package
CN102933199A (zh) 含有烟碱的药物组合物
WO2007095600A3 (en) Disintegrable oral films
JP2011525536A5 (enExample)
EP2081547A2 (fr) Forme galenique pour l'administration par voie trans-muqueuse de principes actifs
RU2009110452A (ru) Галеновые составы алискирена
JP2009543885A5 (enExample)
CA2509023A1 (en) Multilayer dosage forms containing nsaids and triptans
RU2008130763A (ru) Сублингвальный аэрозоль на основе фентанила
WO2010020856A3 (en) Rate modulated delivery of drugs from a composite delivery system
RU2008105825A (ru) Невыплевываемая, быстро распадающаяся пленка для орального применения, содержащая противорвотное средство или средство против мигрени
FI3056187T4 (fi) T3- ja/tai t4-kilpirauhashormonien yksiannoksinen lääkevalmiste
KR20230131956A (ko) 고농도의 활성 성분을 갖는 파우치형 구강 용해 필름
JP2008534562A5 (enExample)
MX2010007281A (es) Composiciones farmaceuticas de amlodipina y valsartan.
TW202019394A (zh) 供置入口腔之劑型